Central New York Clinical Research

Manlius, New York 13104

3 studies enrolling now · 25 studies all time

What they study most

Acute Migraine, Acute Treatment of Migraine, Diabetes Mellitus, Type 2, Episodic Migraine, Healthy, Hypercholesterolemia, Lipidemia, Low Back Pain, Metabolic Syndrome (MetS), Migraine, Migraine With Aura, Migraine Without Aura

Studies at this site

• A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
• A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome — Recruiting now
• A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone — Completed
• A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention — Stopped early
• Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults — Completed
• A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine — Completed
• Randomized Trial in Adult Participants With Acute Migraines — Completed
• Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine — Completed
• Open Label Safety Study in Acute Treatment of Migraine — Completed
• Safety and Efficacy Study in Adult Subjects With Acute Migraines — Completed
• A Study of Tanezumab in Adults With Chronic Low Back Pain — Completed
• Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine — Completed
• Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early
• Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study — Completed
• A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants — Completed
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine — Completed
• Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine — Completed
• Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin — Completed
• A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years. — Completed
• A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes — Completed
• A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects — Completed
• A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction — Completed
• Obese Patients With or Without Comorbidities (RIO-North America) — Completed
• Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder — Completed